Stay
up-to-date
about
RECOVER
Our understanding of Long COVID is constantly evolving with new research findings. Stay informed by reading the latest news and participating in upcoming events.
RECOVER is funding 60+ pathobiology studies to explore how cells in the body interact with each other to cause Long COVID symptoms. These findings may lead to better ways to diagnose, treat, and prevent Long COVID.
By studying millions of patients’ electronic health records (EHRs), RECOVER researchers are gaining understanding about who Long COVID affects, how it affects them, and why some people are more likely to be affected than others.
Recent RECOVER findings provide insights into how changes to the immune system during pregnancy may affect a woman’s risk of developing Long COVID.
Researchers identified six common groups of symptoms experienced by children and adolescents with Long COVID.
Researchers analyzed data from RECOVER’s pediatric observational study to better understand how Long COVID impacts infants, toddlers, and preschool-aged children.
Findings from a recent RECOVER pediatric observational study show that the most common Long COVID symptoms experienced by children 0 to 5 years old can be different than those experienced by older children and adults.
A recent RECOVER Research Review (R3) Seminar held May 13 spotlighted research presented by Carolyn Bramante, MD, MPH (University of Minnesota) and Steve Johnson, PhD (University of Minnesota) exploring how metformin, a widely prescribed medication primarily used to manage type 2 diabetes, may help reduce the risk of Long COVID. The seminar also featured a presentation from Suzanne Vernon, PhD (Bateman Horne Center) on research examining the risk of developing myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) following a COVID-19 infection.
Five RECOVER study sites across the Pacific Northwest teamed up to form a consortium. Consortium members learn from other RECOVER researchers’ findings and share knowledge with the community.
Combining knowledge across different scientific specialties that study biological systems could reveal information that improves the diagnosis of Long COVID and supports the development of personalized Long COVID treatments.
Media InquiriesAre you a member of the media or press? Please direct inquiries to the RECOVER@nih.gov inbox. Please place "MEDIA INQUIRY" in your subject line.